VYGR
Voyager Therapeutics Inc

3,849
Mkt Cap
$227.96M
Volume
831,007.00
52W High
$5.55
52W Low
$2.65
PE Ratio
-1.89
VYGR Fundamentals
Price
$4.10
Prev Close
$4.23
Open
$4.18
50D MA
$3.89
Beta
1.46
Avg. Volume
667,654.10
EPS (Annual)
-$1.13
P/B
1.03
Rev/Employee
$465,122.09
$104.02
Loading...
Loading...

About

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
172

Frequently Asked Questions

What is Market Cap of Voyager Therapeutics Inc?
What is the 52-week high for Voyager Therapeutics Inc?
What is the 52-week low for Voyager Therapeutics Inc?
What is Voyager Therapeutics Inc stock price today?
What was Voyager Therapeutics Inc stock price yesterday?
What is the PE ratio of Voyager Therapeutics Inc?
What is the Price-to-Book ratio of Voyager Therapeutics Inc?
What is the 50-day moving average of Voyager Therapeutics Inc?
How many employees does Voyager Therapeutics Inc have?

Latest VYGR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.